Cargando…

Construction and Immunological Evaluation of an Adenoviral Vector-Based Vaccine Candidate for Lassa Fever

Lassa virus (LASV) is a rodent-borne arenavirus circulating in West African regions that causes Lassa fever (LF). LF is normally asymptomatic at the initial infection stage, but can progress to severe disease with multiorgan collapse and hemorrhagic fever. To date, the therapeutic choices are limite...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Meirong, Li, Ruihua, Li, Yaohui, Yu, Changming, Chi, Xiangyang, Wu, Shipo, Liu, Shulin, Xu, Junjie, Chen, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001012/ https://www.ncbi.nlm.nih.gov/pubmed/33804206 http://dx.doi.org/10.3390/v13030484

Ejemplares similares

Advanced Vaccine Candidates for Lassa Fever
por: Lukashevich, Igor S.
Publicado: (2012)

PROSPECTS OF LASSA FEVER CANDIDATE VACCINES
por: Isaac, Ademusire Babatunde, et al.
Publicado: (2022)

Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever
por: Branco, Luis M, et al.
Publicado: (2010)

Immunology of Adenoviral Vectors in Cancer Therapy
por: Shaw, Amanda Rosewell, et al.
Publicado: (2019)

Construction and application of adenoviral vectors
por: Zhang, Hongbo, et al.
Publicado: (2023)

A Promising Candidate for a Lassa Fever Vaccine
Publicado: (2005)

Identifying immunodominant multi-epitopes from the envelope glycoprotein of the Lassa mammarenavirus as vaccine candidate for Lassa fever
por: Rowaiye, Adekunle Babajide, et al.
Publicado: (2022)

Lassa fever vaccine prospects: identifying immunodominant multi-epitopes as vaccine candidate
por: Nwabueze, Cherechi Omarabia
Publicado: (2023)

In-silico identification of the vaccine candidate epitopes against the Lassa virus hemorrhagic fever
por: Baral, Prabin, et al.
Publicado: (2020)

Modelling seasonality of Lassa fever incidences and vector dynamics in Nigeria
por: McKendrick, James Q., et al.
Publicado: (2023)

Pathogenesis of Lassa Fever
por: Yun, Nadezhda E., et al.
Publicado: (2012)

Vaccine platforms for the prevention of Lassa fever
por: Purushotham, Jyothi, et al.
Publicado: (2019)

Characterization of transgene expression in adenoviral vector-based HIV-1 vaccine candidates
por: Takahashi, Marie-Noëlle, et al.
Publicado: (2010)

On the Front Lines of Lassa Fever
por: Bausch, Daniel G., et al.
Publicado: (2004)

Animal Models of Lassa Fever
por: Sattler, Rachel A., et al.
Publicado: (2020)

Lassa fever — the road ahead
por: Garry, Robert F.
Publicado: (2022)

Use of adenoviral vectors as veterinary vaccines
por: Ferreira, T B, et al.
Publicado: (2005)

Adenoviral Vector Vaccines Antigen Transgene
por: Ertl, Hildegund C.J.
Publicado: (2016)

Targeted adenoviral vectors
por: Vigne, E, et al.
Publicado: (2001)

Xenogenic Adenoviral Vectors
por: Mittal, Suresh K., et al.
Publicado: (2016)

Xenogenic Adenoviral Vectors
por: Both, Gerald W.
Publicado: (2002)

Using Multivalent Adenoviral Vectors for HIV Vaccination
por: Gu, Linlin, et al.
Publicado: (2013)

Editorial: Adenoviral Infection and Immunity, and Adenoviral Vectors for Gene Therapy Applications
por: Zhang, Qiwei, et al.
Publicado: (2022)

Development of a New Vaccine for the Prevention of Lassa Fever
por: Geisbert, Thomas W, et al.
Publicado: (2005)

Non-neutralizing antibodies elicited by recombinant Lassa–Rabies vaccine are critical for protection against Lassa fever
por: Abreu-Mota, Tiago, et al.
Publicado: (2018)

An Adenoviral Vector Based Vaccine for Rhodococcus equi
por: Giles, Carla, et al.
Publicado: (2016)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
por: Ewer, Katie, et al.
Publicado: (2017)

Pathogenesis of lassa fever in cynomolgus macaques
por: Hensley, Lisa E, et al.
Publicado: (2011)

T Cell-Dependence of Lassa Fever Pathogenesis
por: Flatz, Lukas, et al.
Publicado: (2010)

Lassa Fever, Nigeria, 2003 and 2004
por: Omilabu, Sunday Aremu, et al.
Publicado: (2005)

Ribavirin for Lassa Fever Postexposure Prophylaxis
por: Hadi, Christiane M., et al.
Publicado: (2010)

Lassa Fever, Nigeria, 2005–2008
por: Ehichioya, Deborah U., et al.
Publicado: (2010)

Laboratory Diagnosis of Lassa Fever, Liberia
por: Panning, Marcus, et al.
Publicado: (2010)

Lassa fever and global health security
por: The Lancet Infectious Diseases
Publicado: (2018)

Construction and characterization of an adenoviral vector encoding human bone morphogenetic protein-2
por: Peng, Liangquan, et al.
Publicado: (2020)

ADENOVIRAL VECTORS FOR PROTEIN EXPRESSION
por: Von Seggern, Dan J., et al.
Publicado: (1999)

Humoral and cellular immune responses to Lassa fever virus in Lassa fever survivors and their exposed contacts in Southern Nigeria
por: Ugwu, Chinedu, et al.
Publicado: (2022)

Imported lassa fever in Germany: molecular characterization of a new lassa virus strain.
por: Günther, S, et al.
Publicado: (2000)

CELO Fiber1 Knob Is a Promising Candidate to Modify the Tropism of Adenoviral Vectors
por: Sun, Yangyang, et al.
Publicado: (2022)

Rapid Cloning of Novel Rhesus Adenoviral Vaccine Vectors
por: Abbink, Peter, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_joq31qphu3rueo6t75rh0825qe